Drug application
ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)
Drugs@FDA ANDA 213132 · GLENMARK PHARMS LTD
Key facts
| Drug name | ARFORMOTEROL TARTRATE |
|---|---|
| Active ingredients | ARFORMOTEROL TARTRATE |
| Application type | ANDA |
| Application number | 213132 |
| Company | GLENMARK PHARMS LTD |
| Dosage forms | SOLUTION, INHALATION |
| Strength | EQ 0.015MG BASE/2ML |
| Marketing status | Discontinued |
| TE codes | AN |
| Reference listed drug | No |
| Latest submission status date | Jun 22, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.